Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Seikagaku Corporation

Clinical trials sponsored by Seikagaku Corporation, explained in plain language.

Seikagaku Corporation 4548 TOKYO

A biopharmaceutical company focused on glycoscience-based products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New eye drop shows promise for dry eye sufferers in Late-Stage trial

Symptom relief Completed

This Phase 3 trial tested SI-614 eye drops, a modified form of sodium hyaluronate, against placebo in 232 adults with dry eye disease. Participants used the drops four times daily for 84 days. The study measured changes in eye surface staining (a sign of damage) and daily symptom…

Phase: PHASE3 • Sponsor: Seikagaku Corporation • Aim: Symptom relief

Last updated Jun 27, 2026 08:12 UTC